摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methoxycarbonylamino-valeric acid | 756874-11-0

中文名称
——
中文别名
——
英文名称
5-methoxycarbonylamino-valeric acid
英文别名
(4-Carboxy-butyl)-carbamidsaeure-methylester;5-Carbomethoxyamino-valeriansaeure;5-Methoxycarbonylamino-valeriansaeure;5-[(methoxycarbonyl)amino]pentanoic acid;5-(methoxycarbonylamino)pentanoic acid
5-methoxycarbonylamino-valeric acid化学式
CAS
756874-11-0
化学式
C7H13NO4
mdl
——
分子量
175.185
InChiKey
SUONKVQMMFIFIN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    71-72 °C
  • 沸点:
    349.4±25.0 °C(Predicted)
  • 密度:
    1.160±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HYDROXYMETHYL SUBSTITUTED DIHYDROISOXAZOLE DERIVATIVES USEFUL AS ANTIBIOTIC AGENTS<br/>[FR] DERIVES DE DIHYDROISOXAZOLE A SUBSTITUTION HYDROXYMETHYLE POUVANT SERVIR D'AGENTS ANTIBIOTIQUES
    申请人:ASTRAZENECA AB
    公开号:WO2004078753A1
    公开(公告)日:2004-09-16
    Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, (I) R1a is NH(C=W)R5 or (a); W is O or S; R2 and R3 are for example H or F; R1 is for example hydrogen, or halogen; R5 is selected from hydrogen, (2-6C)alkyl (optionally substituted); R6 and R7 are independently selected from hydrogen, and (1-4C)alkyl (optionally substituted); wherein R4 is either a hydroxymethyl substituent on C-4' of the isoxazoline ring; or R4 is a hydroxymethyl substituent on C-5' of the isoxazoline ring and the stereochemistry at C-5' of the isoxazoline ring and at C-5 of the oxazolidinone ring is selected, such that the compound of formula (I) is a single diastereomer; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
    公式(I)的化合物,或其药学上可接受的盐,或其体内可水解的酯,(I)中R1a是NH(C=W)R5或(a);W是O或S;R2和R3例如是H或F;R1例如是氢或卤素;R5从氢,(2-6C)烷基(可选地取代)中选择;R6和R7独立地从氢和(1-4C)烷基(可选地取代)中选择;其中R4是异噁唑环的C-4'上的羟甲基取代基;或R4是异噁唑环的C-5'上的羟甲基取代基,且异噁唑环的C-5'和噁唑烷酮环的C-5的立体化学被选择,使得公式(I)的化合物是单一对映体;它们作为抗菌剂是有用的;并描述了它们的制备方法和含有它们的药物组合物。
  • Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
    申请人:Gravestock Barry Michael
    公开号:US20060270637A1
    公开(公告)日:2006-11-30
    Compounds of the formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, (I) R1a is NH(C═W)R 5 or (a); W is O or S; R 2 and R 3 are for example H or F; R 1 is for example hydrogen, or halogen; R 5 is selected from hydrogen, (2-6C)alkyl (optionally substituted); R 6 and R 7 are independently selected from hydrogen, and (1-4C)alkyl (optionally substituted); wherein R 4 is either a hydroxymethyl substituent on C-4′ of the isoxazoline ring; or R 4 is a hydroxymethyl substituent on C-5′ of the isoxazoline ring and the stereochemistry at C-5′ of the isoxazoline ring and at C-5 of the oxazolidinone ring is selected, such that the compound of formula (I) is a single diastereomer; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
    化合物的公式为(I),或其药学上可接受的盐,或其体内可水解的酯,其中(I) R1a为NH(C═W)R5或(a);W为O或S;R2和R3例如为H或F;R1例如为氢或卤素;R5选择自氢、(2-6C)烷基(可选取取代基);R6和R7独立选择自氢和(1-4C)烷基(可选取取代基);其中R4为在异氧杂环环的C-4'上的羟甲基取代基;或R4为在异氧杂环环的C-5'上的羟甲基取代基,并且异氧杂环环的C-5'和噁唑烷环的C-5的立体化学被选择,使得公式(I)的化合物是单一对映体。这些化合物作为抗菌剂有用,并且描述了制造它们的过程以及含有它们的制药组合物。
  • Oxidative C–N Bond Cleavage of Cyclic Amines with Ammonium Hypochlorite
    作者:Yuya Kaieda、Kosuke Yamamoto、Hiroyuki Toguchi、Natsumi Hanazawa、Masami Kuriyama、Osamu Onomura
    DOI:10.1055/a-2062-8680
    日期:——
    An oxidative C–N bond cleavage of cyclic amines has been developed under metal-free conditions, providing N-Cl-ω-amino acids in moderate to excellent yields. The reactions proceed by using tetramethylammonium hypochlorite (TMAOCl) as an oxidant even on a gram scale. Hofmann–Löffler–Freytag-type reaction of N-Cl-ω-amino acids to form cyclic amino acids has also been demonstrated.
    在无金属条件下开发了环状胺的氧化 C-N 键裂解,以中等到极好的收率提供N -Cl-ω-氨基酸。反应通过使用四甲基次氯酸铵 (TMAOCl) 作为氧化剂进行,即使在克级也是如此。N -Cl-ω-氨基酸形成环状氨基酸的 Hofmann–Löffler–Freytag 型反应也已得到证实。
  • HYDROXYMETHYL SUBSTITUTED DIHYDROISOXAZOLE DERIVATIVES USEFUL AS ANTIBIOTIC AGENTS
    申请人:AstraZeneca AB
    公开号:EP1599471B1
    公开(公告)日:2008-05-28
  • US7192974B2
    申请人:——
    公开号:US7192974B2
    公开(公告)日:2007-03-20
查看更多